Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy
Recent advances in recombinant adeno-associated virus (rAAV) gene therapy for choroideremia show gene replacement to be a promising approach. It is, however, well known that contact of vector solution with plastic materials in the surgical device may result in non-specific adsorption with resulting...
Main Authors: | Patrício, M, Cox, C, Blue, C, Barnard, A, Martinez-Fernandez De La Camara, C, Maclaren, R |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Cell Press
2019
|
פריטים דומים
-
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
מאת: Hironori Okada, et al.
יצא לאור: (2013-01-01) -
An amplification-free CRISPR-Cas12a assay for titer determination and composition analysis of the rAAV genome
מאת: Lei Yu, et al.
יצא לאור: (2024-09-01) -
The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A
מאת: Patrício, M, et al.
יצא לאור: (2018) -
rAAV-mediated subcellular targeting of optogenetic tools in retinal ganglion cells in vivo.
מאת: Chaowen Wu, et al.
יצא לאור: (2013-01-01) -
Crucial aspects for maintaining rAAV stability
מאת: Johannes Lengler, et al.
יצא לאור: (2024-11-01)